
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,228 Listeners

1,713 Listeners

977 Listeners

1,993 Listeners

1,649 Listeners

1,105 Listeners

125 Listeners

337 Listeners

1,044 Listeners

1,320 Listeners

6,097 Listeners

34 Listeners

43 Listeners

21 Listeners

10 Listeners

0 Listeners

80 Listeners

18 Listeners

17 Listeners

3 Listeners